Subsequent candidate gene-, machine learning-, and WES-based rare variant association approaches have generated independent support for the role of TLR7 in severe COVID-19 in males [15–18], with recent estimates suggesting the presence of a TLR7 deficiency in around 1–2% of male cases [15,19]. The gene discussed is TLR7; the disease is COVID-19.